Screener
Integer Holdings ITGR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total sales by Product | ||||||
| Cardiac Rhythm Management & Neuromodulation | $168.26M+4.9% | —— | $169.16M+2.5% | $172M+2.3% | $160.35M+2.2% | |
| Cardio & Vascular | $261.73M+1.1% | —— | $277.15M+15.0% | $286.86M+24.0% | $258.87M+16.7% | |
| Other Markets | $9.58M-47.3% | —— | $21.39M-15.5% | $17.64M-37.9% | $18.18M-37.4% |
FAQ
- How does Integer Holdings break its business down?
- Integer Holdings (ITGR) reports total sales by product across 3 parts — Cardiac Rhythm Management & Neuromodulation, Cardio & Vascular and Other Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Integer Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Integer Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
